NYSE:RDWAerospace & Defense
NASA Grant Puts Redwire’s PIL-BOX Drug Research In Investor Focus
NASA awarded Redwire (NYSE: RDW) an additional US$4 million for drug development research on the International Space Station.
The funding supports Redwire's Pharmaceutical In-space Laboratory, known as PIL-BOX, expanding its existing contract with NASA.
The project focuses on using microgravity to study and manufacture potential future pharmaceutical treatments.
For investors watching the space infrastructure theme, Redwire sits at the intersection of space hardware and applied research,...